WestEnd Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
VCM
VPM
WestEnd Advisors's MRK Position: Q1 2026 in Review
WestEnd Advisors reduced its Merck (MRK) stake by 67% in Q1 2026, selling an estimated $16K and leaving 67 shares worth $8.06K. The position accounts for ﹤0.01% of the portfolio, ranked #88.
WestEnd Advisors first reported a position in MRK in Q3 2019 and has held it in 17 quarters since. The position peaked at $42.6M in Q1 2024. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- WestEnd Advisors held 67 shares of Merck worth $8.06K as of Q1 2026.
- WestEnd Advisors sold 139 Merck shares in Q1 2026, an estimated $16K.
- Merck made up ﹤0.01% of WestEnd Advisors's portfolio in Q1 2026, its #88 holding.
- WestEnd Advisors first reported a position in Merck in Q3 2019 and has held it in 17 quarters since.
- WestEnd Advisors's Merck position peaked at $42.6M in Q1 2024.
- 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on WestEnd Advisors's 13F filing for Q1 2026, filed 22 Apr 2026.